Laxminarayan Bhat is the founder of Reviva Pharmaceuticals. Reviva Pharmaceuticals has raised $138M in total funding. Latest round: IPO.
Laxminarayan Bhat is the founder, President, and CEO of Reviva Pharmaceuticals, a biopharmaceutical company established in 2006. He initially funded the company with $150,000 and raised additional seed funding, followed by $37 million from individual investors. Bhat led Reviva through a SPAC transaction in December 2020, taking it public on NASDAQ, and has since raised close to $100 million in public markets.
Full founder directory · Investor directory · Company funding database · Fundraising library